All registered IC-SCRs must submit annual reports in the prescribed format
“As per the National Guidelines for Stem Cell Research - 2017, at present, there are no approved indications for stem cell therapy other than Haematopoietic Stem Cell Transplantation (HSCT) for haematological disorders. Accordingly, all stem cell therapies other than the above shall be treated as investigational and may be conducted only in the form of clinical trials after obtaining necessary regulatory approvals. Use of stem cells for any other purpose outside the domain of clinical trials will be considered unethical and hence not permissible.”
The National Apex Committee for Stem Cell Research and Therapy (NAC-SCRT) is the apex body constituted by the Department of Health Research, Ministry of Health and Family Welfare, Govt. of India to oversee the activities in the field of stem cell research in India. The NAC-SCRT will examine the scientific, technical, ethical, legal and social issues involving stem cell research and therapy in India.
As per the National Guidelines for Stem Cell Research-2017, all institutions carrying out research on human stem cells must constitute an Institutional Committee for Stem Cell Research (IC-SCR) and register with the National Apex Committee for Stem Cell Research and Therapy (NAC-SCRT). The registration of IC-SCR is mandatory and all the institutions working in this field are required to comply with the guidelines. Know more…